BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/20/2025 10:24:03 AM | Browse: 11 | Download: 42
 |
Received |
|
2024-09-12 09:35 |
|
Peer-Review Started |
|
2024-09-12 09:35 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-02-10 09:08 |
|
Revised |
|
2025-02-19 15:05 |
|
Second Decision |
|
2025-03-31 02:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-03-31 07:31 |
|
Articles in Press |
|
2025-03-31 07:31 |
|
Publication Fee Transferred |
|
2025-02-20 02:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-04-30 07:57 |
|
Publish the Manuscript Online |
|
2025-05-20 03:37 |
| ISSN |
2218-4333 (online) |
| Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Toxicity of dose-escalated, hypofractionated helical tomotherapy for inoperable thoracic esophageal squamous cell carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shu-Min Zhang, Jing Sun, Xiang-Ou Pan, Wen-Chao Zhu and Yong-Kang Zhou |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shu-Min Zhang, Associate Professor, MD, Department of Radiation Oncology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China. zhang.shumin@zs-hospital.sh.cn |
| Key Words |
Radiation therapy; Hypofractionated radiation therapy; Tomotherapy; Esophageal squamous cell carcinoma; Toxicity |
| Core Tip |
Hypofractionated radiotherapy is becoming more popular. However, it is unknown whether it is an optimal choice for esophageal tumors. In addition, the appropriate dose per fraction is unclear. At present, there is no systematic report on these issues. In this study, 47 patients with thoracic esophageal carcinoma treated with radiotherapy at different prescribed doses and doses per fraction were enrolled retrospectively. Toxicity and adverse events were evaluated to determine the acute and long-term treatment effects. It was shown that esophageal toxicity can be tolerated below a prescribed dose of 60 Gy of radiation and less than 2.3 Gy per fraction. |
| Publish Date |
2025-05-20 03:37 |
| Citation |
<p>Zhang SM, Sun J, Pan XO, Zhu WC, Zhou YK. Toxicity of dose-escalated, hypofractionated helical tomotherapy for inoperable thoracic esophageal squamous cell carcinoma. <i>World J Clin Oncol</i> 2025; 16(5): 101378</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i5/101378.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i5.101378 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
